您当前的位置:
首页 >
文章列表页 >
Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice
更新时间:2024-06-18
    • Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice

    • 最新研究发现,加味当归贝母苦参丸能显著抑制H22肝癌小鼠肿瘤生长,并通过调节T细胞免疫活性,为联合免疫检查点抗体治疗肝癌提供实验依据。
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 12, Pages: 87-96(2024)
    • DOI:10.13422/j.cnki.syfjx.20232224    

      CLC: R2-0;R22;R242;R285.5
    • Published:20 June 2024

      Published Online:08 October 2023

      Received:24 July 2023

    扫 描 看 全 文

  • MA Xiaojie,LIU Ben,WANG Lei,et al.Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):87-96. DOI: 10.13422/j.cnki.syfjx.20232224.

  •  
  •  

0

Views

13

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese Medicine Regulates Hepatocellular Carcinoma-related Signaling Pathways: A Review
Da Chaihutang Inhibits Hepatocellular Carcinoma by Regulating p38 MAPK/IL-6/STAT3 Signaling Pathway
Mechanism of Biejiajian Wan Against EMT of Hepatocellular Carcinoma Cells Through NF-κB Signaling Pathway
Investigation on Anti-liver Cancer Potential and Compatibility Characteristics of Fufang Biejia Ruangan Pian from Network Perspective

Related Author

MA Yanhua
GAO Fen
ZHENG Lanlan
GUO Cai
ZHANG Xuan
XIE Jiaojiao
HE Yanfang
YU Chun

Related Institution

First School of Clinical Medicine, Gansu University of Chinese Medicine
School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine
School of Chinese Medicine, Southern Medical University
Air Force Hospital of Southern Theater Command of PLA
Traditional Chinese Medicine-Integrated Hospital of Southern Medical University
0